Fusion Biopsy Market to Record Growth at a CAGR of 11.6% from 2022-2028

 Fusion Biopsy Industry Overview

The global fusion biopsy market size was valued at USD 489.1 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 11.6% from 2021 to 2028.

Increasing prevalence of prostate cancer, growing awareness about the importance of regular clinical interventions, and developing reimbursement policies are factors likely to boost the demand for targeted MR/ultrasound biopsy systems over the forecast period. The global number of fusion biopsy procedures declined by around 50.0% during the first semester of the COVID-19 pandemic. Among the procedures that happened during this time, prostate MRI was preferred in most hospitals. The number of procedures, and thus, the demand for new devices resumed after July 2020 as the number of the cases stabilized at a global level. The low-risk patients were managed by an active surveillance strategy which helped minimize the hospital visits associated with COVID-19 risks. Availability of COVID-19 vaccines and resuming procedures with strict guidelines are expected to restore market growth by the end of 2021.

Gather more insights about the market drivers, restrains and growth of the Global Fusion Biopsy market

The primary diagnostic test of prostate cancer includes prostate-specific antigen and digital rectal examination. If this preliminary test shows abnormal results, then further ultrasound imaging is recommended. However, the ultrasound scans have a high possibility to miss significant tumors, especially which are smaller in size and may cause clinical complications in the future. Therefore, urologists refrain to take risks and try to make a diagnosis as promptly and accurately as possible. This has led to the growing demand for prostate biopsy procedures contemplating its safety, reliability, and sensitivity in prostate cancer diagnosis. The government and private bodies are committed to improving the health outcomes for men with prostate cancer by making significant investments into R&D for early and accurate diagnostic tools. For instance, since 2013, the government of Australia has spent over USD 84 million in prostate cancer treatment and diagnostic research through Cancer Australia, Prostate Cancer Research Foundation Australia, and National Health Medical Research Council Australia. Similarly, in October 2018, the U.K. government announced a budget of USD 19 million dedicated for the procurement of advanced diagnostic scanners, as well as training radiologists to deliver medical services for prostate cancer.

Browse through Grand View Research's Medical Devices Industry Research Reports.

  • Nurse Call Systems Market - The global nurse call systems market size was valued at USD 1.5 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 11.96% from 2022 to 2030. 
  • Robotic Prosthetics Market - The global robotic prosthetics market size was valued at USD 1,269.6 million in 2021. It is anticipated to progress at a compounded annual growth rate (CAGR) of 9.2% from 2022 - 2030. 

Fusion Biopsy Market Segmentation

Grand View Research has segmented the global fusion biopsy market on the basis of biopsy route, end-use, and region:

Fusion Biopsy Route Outlook (Revenue, USD Million; 2016 - 2028)

  • Transrectal
  • Transperineal

Fusion Biopsy End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Hospitals
  • Diagnostic Centers
  • Ambulatory Care Center

Fusion Biopsy Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

Key Companies profiled:

Some prominent players in the global Fusion Biopsy market include

  • MedCom
  • ESAOTE SPA
  • KOELIS
  • Focal Healthcare
  • GeoScan Medical
  • UC-Care Medical Systems Ltd.

Order a free sample PDF of the Fusion Biopsy Market Intelligence Study, published by Grand View Research.

Comments

Post a Comment

Popular posts from this blog

Spinal Implants & Devices Market Forecast Analysis by Manufacturer, Types, Applications and Regions 2023 – 2030

  Spinal Implants & Devices Industry Overview The global  Spinal Implants & Devices Market  size is expected to reach USD 19.0 billion by 2030 and is expected to expand at a CAGR of 5.2% in the forecast period, from 2023 to 2030, according to a new report by Grand View Research, Inc. The growing number of vehicular accidents is leading to increasing new cases of spinal cord injuries (SCIs). Other causes of SCIs include falls, violence, acts of violence, sports and recreation injuries, and diseases. Vehicular or road accidents and falls account for the majority of SCI cases. Fall-induced SCI is common among people aged 65 years and above. Acts of violence such as gunshot wounds or knife wounds account for around 12% of SCI cases. Sports activities such as diving in shallow water and impact sports lead to nearly 10% of SCIs. Cancer, osteoporosis, arthritis, and inflammation of the spinal cord also cause SCI. Based on National Spinal Cord Injury Statistical Center da...
Read more

Latin America Pharmaceutical Contract Manufacturing & Research Services Market Overview, Cost Structure Analysis and Forecast to 2030

  Latin America Pharmaceutical Contract Manufacturing & Research Services Industry Overview The  Latin America Pharmaceutical Contract Manufacturing & Research Services Market  size is expected to reach USD 40.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 7.5% from 2022 to 2030. The low cost of drug registration in Latin American countries and the economic growth are the key factors contributing to progress in this region. Moreover, factors such as the growing demand for generics, rising investments in R&D, the growing geriatric population, and the increasing burden of chronic diseases are responsible for market growth. The outbreak of COVID-19 has boosted the market growth as companies have increased investments in R&D and manufacturing to develop vaccines and drugs against the COVID-19. During the coronavirus outburst, the supply chains of biopharmaceutical companies remained robust...
Read more

Mobile Phone Insurance Market - Global Industry Insights, Trends and Growth Opportunity Analysis to 2028

  Mobile Phone Insurance Industry Overview The global mobile phone insurance market size was valued at USD 23.3 billion in 2020. It is expected to expand a compound annual growth rate (CAGR) of 12.6% from 2021 to 2028. Increasing incidents of accidental damage, phone thefts, virus infection, and device malfunction are expected to drive market growth over the forecast period. These incidents have impelled customers to look for ways to safeguard their mobile phones and thereby, adopt mobile phone coverage policies. Mobile phone insurance helps consumers avoid high replacement costs in case their mobile phone is lost or faces a breakdown. A mobile phone insurance policy usually covers physical damage, internal coverage failure, theft and loss protection, and virus and data protection, among others. Gather more insights about the market drivers, restrains and growth of the   Global   Mobile Phone Insurance market Mobile phones serve as a platform for entertainment, education,...
Read more